EGFR and prostate carcinoma: Interestingly, we have recently reported that luteolin also blocks EGFR gene transcription and a number of genes in the EGFR signaling pathway in PC-3 human prostate cancer cells demonstrating that this bioflavonoid apparently targets growth regulatory pathways (3).